Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Tonix Pharmaceuticals Holding (TNXP) Net Income towards Common Stockholders (2023 - 2025)

Historic Net Income towards Common Stockholders for Tonix Pharmaceuticals Holding (TNXP) over the last 3 years, with Q3 2025 value amounting to -$32.0 million.

  • Tonix Pharmaceuticals Holding's Net Income towards Common Stockholders fell 12521.64% to -$32.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$99.2 million, marking a year-over-year increase of 2664.03%. This contributed to the annual value of -$130.0 million for FY2024, which is 1146.77% down from last year.
  • According to the latest figures from Q3 2025, Tonix Pharmaceuticals Holding's Net Income towards Common Stockholders is -$32.0 million, which was down 12521.64% from -$28.3 million recorded in Q2 2025.
  • Tonix Pharmaceuticals Holding's Net Income towards Common Stockholders' 5-year high stood at -$14.2 million during Q3 2024, with a 5-year trough of -$78.8 million in Q2 2024.
  • Its 3-year average for Net Income towards Common Stockholders is -$29.2 million, with a median of -$27.3 million in 2023.
  • The largest annual percentage gain for Tonix Pharmaceuticals Holding's Net Income towards Common Stockholders in the last 5 years was 6411.09% (2025), contrasted with its biggest fall of 12521.64% (2025).
  • Quarter analysis of 3 years shows Tonix Pharmaceuticals Holding's Net Income towards Common Stockholders stood at -$27.3 million in 2023, then rose by 19.08% to -$22.1 million in 2024, then tumbled by 44.79% to -$32.0 million in 2025.
  • Its Net Income towards Common Stockholders was -$32.0 million in Q3 2025, compared to -$28.3 million in Q2 2025 and -$16.8 million in Q1 2025.